Due to its segmented genome, influenza viruses can exchange gene segments during replication within a host cell and form a huge diversity of strains, which constitute the basis for viral pathogen evolution and maintenance. Consequently, every year epidemiologists deal with new virus variants that cause seasonal outbreaks of influenza and represent a challenge to vaccine production and influenza control. Therefore, sequencing segments of the influenza virus is essential to anticipate the impact of infection on the community. In the last three years, an earlier pattern of influenza virus circulation was observed, starting in late summer and peaking in winter. In addition, an increase in influenza B episodes was noted. Hence, in this study, we aim to perform phylogenetic analysis on whole genome of influenza B virus detected in HSCT recipients at Amaral Carvalho Hospital (ACH) and follow the genetic evolutionary pattern and antigenic variability of viral strains to evaluate the occurrence of adaptive changes in the influenza B genome. Respiratory viruses (RV), including influenza B, are major causes of morbidity and mortality in HSCT recipients. At Amaral Carvalho Foundation, RV control policies include respiratory symptom surveillance followed by RV detection in nasal wash (NW) samples by indirect immunofluorescence assay. One aliquot of NW sample is routinely stored for back up or for further studies. Positive influenza B samples identified from 2010 to 2017 will be selected and subsequently subjected to whole-genome sequencing using next-generation sequencing. For whole-genome sequencing, total RNA will be extracted by using QIAamp Viral RNA Mini kit (Qiagen, Hilden, Germany). cDNA will be prepared using SuperScript method as manufacturers instructions (Invitrogen, Carlsbad, CA, USA) and finally processed by Illumina sequencing following four main steps: 1) library preparation; 2) cluster generation 3) sequencing, and 4) data analysis. This advanced molecular gene detection shows genetic variations among different influenza virus particles in a single sample and will allow us to characterize and understand how influenza B viruses are evolving and mutating. In addition, we will investigate the match between the viruses detected and the vaccine strain in the corresponding year of diagnosis.
